Relationship between COX-2 expression and clinicopathological features of colorectal cancers
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 8
- DOI:
- No doi available
- Key Word:
- COX-2;colorectal cancer;prognosis;Cox proportional hazards regression
Abstract： Background Cyclo-oxgenase 2 (COX-2) is involved in prostaglandin synthesis in central nervous system, and it also plays a role in human carcinogenesis. Our purpose of this study is to investigate the COX-2 expression in different development stages of colorectal cancer, and to discuss the relationship between the gene expression and clinicopathological features of the cancer.Methods COX-2 expression was examined by immunohistochemical staining in 76 surgical specimens of colorectal cancer (44 of advanced stage and 32 of early stage), thirty-three adenomas and 18 normal colonic mucosal tissues taken by endoscopic biopsy. Kaplan-Meier survival curves and Cox proportional hazards regression were used to evaluate the relation of COX-2 to prognosis.Results COX-2 expression, divided into 4 grades from "-" to"+++", is respectively 83.3%, 16.7%, 0% and 0% in normal colonic mucosal tissues; 12.1%, 42.4%, 36.4% and 9.1% in adenomas; 6.3%, 28.1%, 46.9% and 18.7% in early colorectal cancers (ECCs), and 6.8%, 20.5%, 18.2% and 54.5% in advanced colorectal cancers (CRCs). The differences in COX-2 expression between advanced CRCs and early colorectal cancers (ECCs) as well as between the advanced CRCs and adenomas were statistically significant (P<0.01); but there was no significant difference between ECCs and adenomas. Kaplan-Meier survival analysis showed a significant difference in the survival curves between low high COX-2 groups (P<0.05). Cox proportional hazards regression showed that COX-2 expression was related to poorer long-term outcome with a hazard ratio of 2.665 unadjusted for other variables (P<0.05), and COX-2 expression was an independent risk factor of poor prognosis.Conclusions COX-2 expression is gradually up-regulated in the development from normal epithelium to adenomas and from ECCs to advanced CRCs. Alhough the COX-2 protein can not be regarded as a tumor marker to diagnose CRCs early, COX-2 expression can be regarded as an independent risk factor of poor prognosis for postoperative patients with advanced CRCs.
- [1]H, Wolff,K, Saukkonen,S, Anttila,etc.Expression of cyclooxygenase-2 in human lung carcinoma.[J].1998,58.
- [2]G, Shiota,M, Okubo,T, Noumi,etc.Cyclooxygenase-2 expression in hepatocellular carcinoma.[J].1900,46.
- [3]C E, Eberhart,R J, Coffey,A, Radhika,etc.Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.[J].1994,107.
- [4]A, Ristim?ki,N, Honkanen,H, J?nk?l?,etc.Expression of cyclooxygenase-2 in human gastric carcinoma.[J].1997,57.
- [5]Chieko Yokoyama,Tadashi Tanabe.Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme[J].1989,165(2).
- [6]T, Kosaka,A, Miyata,H, Ihara,etc.Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.[J].1994,221.
- [7]K C, Zimmermann,M, Sarbia,A A, Weber,etc.Cyclooxygenase-2 expression in human esophageal carcinoma.[J].1999,59.
- [8]Zimmerman GA.,Kutchera W.,Matsunami N.,etc.Prostaglandin H Synthase 2 is Expressed Abnormally in Human Colon Cancer - Evidence for a Transcriptional Effect[J].1996,93(10).
- [9]H, Bamba,S, Ota,A, Kato,etc.High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.[J].1999,83.
- [10]H, Sano,Y, Kawahito,R L, Wilder,etc.Expression of cyclooxygenase-1 and -2 in human colorectal cancer.[J].1995,55.
- [11]Hwang D,Levine E,Byrne J,etc.Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.[J].1998,90(6).
- [12]F M, Giardiello,S R, Hamilton,A J, Krush,etc.Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.[J].1993,328(18).
- [13]Saito S,Tsuruo T,Shibata Y,etc.Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.[J].2000,83(3).
- [14]M, Oshima,J E, Dinchuk,S L, Kargman,etc.Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).[J].1996,87.
- [15]R N, Dubois,S B, Abramson,L, Crofford,etc.Cyclooxygenase in biology and disease.[J].1998,12(12).